Your browser doesn't support javascript.
loading
BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients.
Kote-Jarai, Z; Leongamornlert, D; Saunders, E; Tymrakiewicz, M; Castro, E; Mahmud, N; Guy, M; Edwards, S; O'Brien, L; Sawyer, E; Hall, A; Wilkinson, R; Dadaev, T; Goh, C; Easton, D; Goldgar, D; Eeles, R.
Affiliation
  • Kote-Jarai Z; Oncogenetics Team, The Institute of Cancer Research, Sutton SM2 5NG, UK. zsofia.kote-jarai@icr.ac.uk
Br J Cancer ; 105(8): 1230-4, 2011 Oct 11.
Article in En | MEDLINE | ID: mdl-21952622
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Genetic Testing / Age of Onset / Genes, BRCA2 Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2011 Type: Article Affiliation country: United kingdom
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Genetic Testing / Age of Onset / Genes, BRCA2 Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2011 Type: Article Affiliation country: United kingdom